NASDAQ:PALI

Palisade Bio Stock Forecast, Price & News

$4.11
+0.18 (+4.58 %)
(As of 06/11/2021 12:00 AM ET)
Add
Compare
Today's Range
$3.96
$4.15
50-Day Range N/A
52-Week Range
$3.00
$16.02
Volume599,649 shs
Average Volume892,358 shs
Market Capitalization$11.84 million
P/E RatioN/A
Dividend YieldN/A
Beta1.81
30 days | 90 days | 365 days | Advanced Chart
Receive PALI News and Ratings via Email

Sign-up to receive the latest news and ratings for Palisade Bio and its competitors with MarketBeat's FREE daily newsletter.


About Palisade Bio

Leading BioSciences, Inc. develops therapeutics to improve human health through therapeutic protection of the gastrointestinal mucosal barrier. The company was founded in 2005 and is based in Carlsbad, California.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.00 out of 5 stars

Medical Sector

1943rd out of 2,099 stocks

Biological Products, Except Diagnostic Industry

193rd out of 198 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Palisade Bio (NASDAQ:PALI) Frequently Asked Questions

What stocks does MarketBeat like better than Palisade Bio?

Wall Street analysts have given Palisade Bio a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Palisade Bio wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Palisade Bio's next earnings date?

Palisade Bio is scheduled to release its next quarterly earnings announcement on Friday, June 18th 2021.
View our earnings forecast for Palisade Bio
.

Who are Palisade Bio's key executives?

Palisade Bio's management team includes the following people:
  • Dr. Thomas M. Hallam Ph.D., CEO & Director
  • Mr. John J. Rodenrys, Co-Founder, Exec. VP of R&D and CTO
  • Mr. J. D. Finley, Chief Financial Officer & Principal Financial and Accounting Officer
  • Ms. Sharon McBrayer, Director of Operations
  • Mr. Charles C. Wells, Sr. VP of HR (Age 70)
  • Dr. Michael John Dawson M.D., Chief Medical Officer
  • Mr. Ryker Willie, Director of Fin. & Controller

Who are some of Palisade Bio's key competitors?

What is Palisade Bio's stock symbol?

Palisade Bio trades on the NASDAQ under the ticker symbol "PALI."

How do I buy shares of Palisade Bio?

Shares of PALI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Palisade Bio's stock price today?

One share of PALI stock can currently be purchased for approximately $4.11.

How much money does Palisade Bio make?

Palisade Bio has a market capitalization of $11.84 million and generates $10,000.00 in revenue each year.

What is Palisade Bio's official website?

The official website for Palisade Bio is leadingbiosciences.com.

Where are Palisade Bio's headquarters?

Palisade Bio is headquartered at 20271 Goldenrod Lane, Germantown MD, 20876.

How can I contact Palisade Bio?

Palisade Bio's mailing address is 20271 Goldenrod Lane, Germantown MD, 20876. The company can be reached via phone at 858 704 4900 or via email at [email protected]


This page was last updated on 6/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.